Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 929-942, October 2007

Economic consequences of established rheumatoid arthritis and its treatment

  • Arthur Kavanaugh, MD (Director, Center for Innovative Therapy and Professor of Medicine, University of California, USA)

      Affiliations

    • Corresponding Author InformationTel.: +1 858 657 7044; Fax: +1 858 657 7045.

Division of Rheumatology, Allergy and Immunology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0943, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6942(07)00061-7

doi:10.1016/j.berh.2007.05.005

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 929-942, October 2007

Article Tools